R.S. BUDEPRESS LEVO : Uses, Dosage, Side Effects, Price, Composition and More.

R.S. BUDEPRESS LEVO 

Levosalbutamol Hydrochloride (1.25mg) & Budesonide (0.5mg) Inhalation Suspension

R.S. BUDEPRESS LEVO, combining Levosalbutamol Hydrochloride (1.25mg) and Budesonide (0.5mg) in inhalation suspension, stands as a crucial medication in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This inhalation suspension offers a comprehensive approach to address both bronchospasm and inflammation associated with these conditions. Here, we explore its uses, dosage, side effects, price, composition, and more, empowering patients and healthcare providers with essential information.

Uses:

R.S. BUDEPRESS LEVO is primarily indicated for the maintenance treatment of asthma and COPD in patients who require a combination of a long-acting beta2-adrenergic agonist (LABA) and an inhaled corticosteroid (ICS). Levosalbutamol Hydrochloride, a LABA, acts as a bronchodilator, relaxing the muscles in the airways and facilitating easier breathing. Budesonide, an ICS, reduces airway inflammation, thereby preventing asthma attacks and COPD exacerbations. Together, they provide comprehensive symptom control and improve lung function in affected individuals.

Dosage:

The dosage of R.S. BUDEPRESS LEVO is individualized based on the severity of the patient's condition and their response to therapy. Generally, the recommended dosage involves inhaling the contents of one vial (1.25mg of Levosalbutamol Hydrochloride and 0.5mg of Budesonide) twice daily, using a suitable nebulizer device. Dosage adjustments may be warranted under the guidance of a healthcare provider to achieve optimal therapeutic outcomes while minimizing the risk of adverse effects.

Side Effects:

While R.S. BUDEPRESS LEVO is effective in managing respiratory conditions, it may be associated with certain side effects. Common adverse effects include headache, throat irritation, cough, and tremors. Additionally, individuals may experience palpitations, increased heart rate, or changes in blood pressure. Rarely, more severe adverse reactions such as paradoxical bronchospasm, allergic reactions, or adrenal suppression may occur. Patients should promptly report any concerning symptoms to their healthcare provider for evaluation and management.

Price:

The price of R.S. BUDEPRESS LEVO can vary depending on factors such as brand, dosage strength, and geographic location. It is available in the form of inhalation suspension vials for use with nebulizers. Patients are advised to compare pricing options at different pharmacies or online platforms to identify cost-effective solutions. Health insurance coverage may help mitigate medication expenses for eligible individuals, ensuring access to this essential therapy.

Composition:

Each vial of R.S. BUDEPRESS LEVO inhalation suspension contains 1.25mg of Levosalbutamol Hydrochloride and 0.5mg of Budesonide as the active ingredients. Levosalbutamol Hydrochloride acts as a selective beta2-adrenergic agonist, while Budesonide functions as a corticosteroid with potent anti-inflammatory properties. The inhalation suspension also contains inactive ingredients such as sodium chloride, water for injection, and hydrochloric acid, ensuring proper nebulization and inhalation.

Conclusion:

In conclusion, R.S. BUDEPRESS LEVO emerges as a cornerstone in the management of asthma and COPD, offering comprehensive symptom control and improved lung function. By combining the bronchodilator effects of Levosalbutamol Hydrochloride with the anti-inflammatory properties of Budesonide, this inhalation suspension provides a synergistic approach to addressing respiratory conditions. Healthcare providers play a pivotal role in guiding patients through optimal treatment regimens, monitoring for potential side effects, and ensuring safe and effective utilization of R.S. BUDEPRESS LEVO. With proper management, individuals can breathe easier and enjoy a better quality of life with R.S. BUDEPRESS LEVO. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  

 For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

  BUY NOW